Review on the alteration of gut microbiota: the role of HIV infection and old age.

Human immunodeficiency virus (HIV) infection, results in gut microbiota alteration and this have association with the immune activation and chronic inflammation. Gastrointestinal tract (GIT) is a primary site of viral replication and thus HIV-induced loss of T-helper (Th) cells in the gut causes impairments in intestinal barriers resulting in disruptions in intestinal immunity and precipitating into gut dysbiosis. Here we show that late HIV diagnosis can negatively affect the immunological, virological, and clinical prognosis of the patients with its higher implication at an older age. Furthermore, the review indicates antiretroviral therapy (ART) to have shown to effect the gut microbiota. We discussed the use of probiotics and prebiotics that have been indicated to play a promising role in reversing gut microbiota alteration in HIV patients. Though there are several studies reported as such alterations in gut microbiota concerning HIV infection, there is a need to provide comprehend updates. It is; therefore, the objective of this review is to present most recently available evidences on alteration of gut microbiota among HIV patients. ------------------------------------------------------------------------------------------------------------ Key words: HIV, AIDS, Gut microbiota, late diagnosis, old age, ART, Probiotics, Prebiotics.

[1]  R. Brookmeyer,et al.  Effects of HIV viremia on the gastrointestinal microbiome of young MSM , 2019, AIDS.

[2]  M. Obrenovich,et al.  The Transformative Possibilities of the Microbiota and Mycobiota for Health, Disease, Aging, and Technological Innovation , 2019, Biomedicines.

[3]  Jennifer M. Brulc,et al.  Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity , 2019, Microbiome.

[4]  S. Sureshchandra,et al.  Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection , 2019, Front. Immunol..

[5]  Miranda E. Kroehl,et al.  Among older adults, age-related changes in the stool microbiome differ by HIV-1 serostatus , 2019, EBioMedicine.

[6]  N. Joseph,et al.  Prognostic Factors of Mortality among Adult Patients on Antiretroviral Therapy in India: A Hospital Based Retrospective Cohort Study , 2019, BioMed research international.

[7]  M. M. Pires,et al.  The impact of in utero HIV exposure on gut microbiota, inflammation, and microbial translocation , 2019, Gut microbes.

[8]  P. Palma,et al.  Distinct gut microbiota profile in ART-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers. , 2019, AIDS.

[9]  J. Hov,et al.  Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals , 2018, AIDS.

[10]  M. Siedner Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework , 2019, Journal of aging and health.

[11]  M. Obrenovich Leaky Gut, Leaky Brain? , 2018, Microorganisms.

[12]  P. Loke,et al.  Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals , 2018, Scientific Reports.

[13]  Xi Chen,et al.  Changes and determinants of health-related quality of life among people newly diagnosed with HIV in China: a 1-year follow-up study , 2018, Quality of Life Research.

[14]  Yuanda Song,et al.  Probiotics and Their Potential Preventive and Therapeutic Role for Cancer, High Serum Cholesterol, and Allergic and HIV Diseases , 2018, BioMed research international.

[15]  Wolfgang Lieb,et al.  Reduced microbiome alpha diversity in young patients with ADHD , 2018, PloS one.

[16]  H. Luma,et al.  Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences , 2018, BMC Infectious Diseases.

[17]  J. Xie,et al.  Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients , 2018, Front. Microbiol..

[18]  Hongzhou Lu,et al.  Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count , 2018, Emerging Microbes & Infections.

[19]  M. Ferrer,et al.  Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota , 2018, AIDS.

[20]  C. Delpierre,et al.  Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score , 2018, PloS one.

[21]  Hong Wang,et al.  Alterations in the gut microbiota of patients with acquired immune deficiency syndrome , 2018, Journal of cellular and molecular medicine.

[22]  Jeonghyun Choi,et al.  Influence of Altered Gut Microbiota Composition on Aging and Aging-Related Diseases , 2018, Journal of lifestyle medicine.

[23]  G. Reyes-Terán,et al.  Impact of antiretroviral drugs on the microbiome: unknown answers to important questions , 2017, Current opinion in HIV and AIDS.

[24]  C. Tremblay,et al.  Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease , 2017, Current opinion in HIV and AIDS.

[25]  D. Kitzman,et al.  Gut microbiome and aging: Physiological and mechanistic insights , 2017, Nutrition and healthy aging.

[26]  A. Gori,et al.  Altered gut microbiome composition in HIV infection: causes, effects and potential intervention , 2018, Current opinion in HIV and AIDS.

[27]  Giorgio La Fata,et al.  Recent Development of Prebiotic Research—Statement from an Expert Workshop , 2017, Nutrients.

[28]  M. Feldman,et al.  Socio-behavioral risk factors among older adults living with HIV in Thailand , 2017, PloS one.

[29]  L. Laghi,et al.  Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing , 2017, Front. Immunol..

[30]  Mohammed Biset Ayalew Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review , 2017, AIDS research and treatment.

[31]  M. Ayalew Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review. , 2017 .

[32]  F. Turroni,et al.  Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients , 2017, Scientific Reports.

[33]  M. Ferrer,et al.  The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects , 2016, Mucosal Immunology.

[34]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics ( ISAPP ) consensus statement on the definition and scope of prebiotics , 2018 .

[35]  E. Costantini,et al.  Microbiota and Probiotics in Health and HIV Infection , 2017, Nutrients.

[36]  E. N. Cavallari,et al.  Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus–Positive Patients: Preliminary Results of a New Study Approach , 2017, International journal of tryptophan research : IJTR.

[37]  F. Bushman,et al.  Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors , 2017, AIDS.

[38]  G. Rossi,et al.  Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART‐treated HIV‐1‐positive patients , 2017, Immunity, inflammation and disease.

[39]  M. Surette,et al.  Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction , 2017, Cell host & microbe.

[40]  A. Artacho,et al.  Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial , 2017, PloS one.

[41]  G. Tambussi,et al.  Immunosenescence and hurdles in the clinical management of older HIV-patients , 2017, Virulence.

[42]  M. McCarter,et al.  Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation , 2017, AIDS.

[43]  G. Dolci,et al.  Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study , 2017, AIDS Research and Therapy.

[44]  P. Kanki,et al.  Treatment Outcomes Among Older Human Immunode ! ciency Virus-Infected Adults in Nigeria , 2017 .

[45]  Christopher M. Taylor,et al.  Analysis of the intestinal microbial community and inferred functional capacities during the host response to Pneumocystis pneumonia , 2016, Experimental lung research.

[46]  Lanjuan Li,et al.  Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population , 2016, Scientific Reports.

[47]  M. Dichgans,et al.  Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke , 2016, The Journal of Neuroscience.

[48]  C. Robert,et al.  Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen , 2016, BMJ open gastroenterology.

[49]  N. Zmora,et al.  The gut microbiome in human immunodeficiency virus infection , 2016, BMC Medicine.

[50]  R. Osawa,et al.  Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study , 2016, BMC Microbiology.

[51]  A. d’Arminio Monforte,et al.  Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy , 2016, AIDS.

[52]  Z. Grossman,et al.  Characteristics and Outcome of Patients Diagnosed With HIV at Older Age , 2016, Medicine.

[53]  J. Brenchley,et al.  Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial , 2015, PloS one.

[54]  S. Perna,et al.  Review on microbiota and effectiveness of probiotics use in older. , 2015, World journal of clinical cases.

[55]  E. Shankar,et al.  Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection. , 2015, World journal of virology.

[56]  R. Haubrich,et al.  Changes in Metabolic Syndrome Status After Initiation of Antiretroviral Therapy , 2015, Journal of acquired immune deficiency syndromes.

[57]  A. Kane,et al.  Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. , 2015, The Journal of infectious diseases.

[58]  Yihong Li,et al.  Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes , 2014, PloS one.

[59]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[60]  P. Cotter,et al.  Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ , 2013, Therapeutic advances in gastroenterology.

[61]  S. Salminen,et al.  Probiotics modulate the Bifidobacterium microbiota of elderly nursing home residents , 2009, AGE.

[62]  L. Jost Partitioning diversity into independent alpha and beta components. , 2007, Ecology.

[63]  P. Gopal,et al.  Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. , 2007, The journal of nutrition, health & aging.

[64]  M. Mcmurdo,et al.  Characterization of Bacterial Communities in Feces from Healthy Elderly Volunteers and Hospitalized Elderly Patients by Using Real-Time PCR and Effects of Antibiotic Treatment on the Fecal Microbiota , 2004, Applied and Environmental Microbiology.